区分1型和2型心肌梗塞的生物标志物概况
Marco Mele1, Francesco Mautone2, Ilaria Ragnatela2
1Cardiothoracic Department, Policlinico Riuniti Foggia, Foggia Italy.
Heart & lung : the journal of critical care
|January 3, 2025
概括
区分1型心肌梗塞 (T1MI) 和2型心肌梗塞 (T2MI) 是非常重要的. 生物标志物概况,特别是高灵敏性热素I (hs-cTnI) 与前素 (PCT) 的比率,可以在非ST升高心肌梗塞 (NSTEMI) 患者中有效区分T1MI与T2MI.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 急性心脏病护理 急性心脏病护理
背景情况:
- 在患者入院和住院期间,准确区分1型心肌梗塞 (T1MI) 和2型心肌梗塞 (T2MI) 是非常重要的.
- 错误分类可能导致不必要的侵入性手术和不适当的入院急性心脏病治疗单位.
- 使用易于获得的生物标志物建立简单的诊断档案可以改善临床决策.
研究的目的:
- 定义一个简单的生物标志物概况,以区分T1MI和T2MI.
- 评估常用生物标志物的实用性,以区分这些心肌梗塞类型.
- 在非ST升高急性心肌梗塞 (NSTEMI) 的患者中确定T1MI的预测因子.
主要方法:
- 对213名连续诊断为NSTEMI的患者进行前性观察性研究.
- 基于临床和仪器发现的T1MI,T2MI或非缺血性急性心肌损伤 (NAMI) 的最终诊断.
- 对高灵敏度的托罗邦素I (hs-cTnI),CK-MB,C反应蛋白 (CRP),普卡尔西托尼 (PCT) 和NT-proBNP的评估.
主要成果:
- Hs-cTnI峰值/PCT比率和hs-cTnI峰值/NT-proBNP比率显著区分了T1MI与T2MI以及T2MI+NAMI.
- Hs-cTnI峰值/PCT比率被确定为T1MI (OR1.03,95%CI1.01-1.06,p <0.05) 的预测指标,准确度为0.704.
- 在T2MI和NAMI组之间没有发现显著差异.
结论:
- 入院生物标志物概况,特别是hs-cTnI与PCT和NT-proBNP的比率,可以在NSTEMI患者中区分T1MI和T2MI.
- 这种生物标志物概况有助于避免不必要的侵入性检查,并优化急性心脏病治疗单位的入院.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56